Article Figures & Data
Figures
- Figure 1.
Overall survival (OS) and disease-free survival (DFS) curves of patients with gastric cancer with nodal positive status (A, B).
- Figure 2.
The implications of NRG4 alone and in combination with ERBB4 in the overall survival (OS) of patients with gastric cancer are illustrated in A and B. Patients with integrated expression of MLN64/NRG4/ERBB4 had a significantly shortened OS (C).
- Figure 3.
Survival curves of patients in subgroups of cohort B. A) Overall survival (OS) curve of patients who received neoadjuvant chemotherapy (NAC). Patients were subclassified into MLN64 high and low groups, B) based on patients’ chemo-response, C) MLN64 expression within the NAC responsive group, D) integrated expression of MLN64/NRG4/ERBB4.
- Figure 4.
ECIS-based assessment of cell adhesion and migration at 4,000 Hz for both HGC27 (A, B) and AGS (C, D) cell models.
- Figure 5.
ECIS-based assessment of cell adhesion at 4,000 Hz for AGS (C, D) cell models under different treatments.
